Identification of Therapeutic Vulnerabilities in Small Cell Neuroendocrine Prostate Cancer

PURPOSE: Small-cell neuroendocrine prostate cancer (SCNPC) exhibits an aggressive clinical course and incidence rates appear to be increasing following resistance to potent androgen receptor (AR) antagonists. Currently, treatment options are limited and few model systems are available to identify ne...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Corella, Alexandra N., Ordonio, Ma Victoria Andrea Cabiliza, Coleman, Ilsa, Lucas, Jared M., Kaipainen, Arja, Nguyen, Holly M., Sondheim, Daniel, Brown, Lisha G., True, Lawrence, Lee, John, MacPherson, David, Nghiem, Paul, Gulati, Roman, Morrissey, Colm, Corey, Eva, Nelson, Peter S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7124974/
https://ncbi.nlm.nih.gov/pubmed/31806643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-0775
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados